AUTHORS
Bonyan Qudah, PhD, Rachel Rodenbach, MD, MS2, Majd Allawi, N/A3, Toby Christopher Campbell, MD, MS4
AFFILIATIONS
1 University of Wisconsin-Madison, Madison, Wisconsin, United States
2 University of Rochester Medical Center, Rochester, New York, United States
3 University of Wisconsin-Madison, Madison, Wisconsin, United States
4 University of Wisconsin-Madison, Madison, Wisconsin, United States
ABSTRACT
Background: Allogeneic stem cell transplantation (allo-SCT) can offer long-term cure for a variety of hematological cancers and disorders, but it comes with substantial risks impacting quality of life. The inherent uncertainty and complexity of the allo-HSCT experience make hematologist-patient communication about allo-SCT challenging. There is a need for a communication tool to help hematologists deliver clear and consistent information about allo-SCT alongside other treatment options and maximize patients’ ability to make an informed decision that aligns with their goals and preferences. Objectives: This research aims to (1) identify the needs of hematologists and patients referred for allo-SCT consultations regarding a communication intervention and (2) develop a user-centered, communication tool grounded in Self-Determination Theory. Methods: Using a participatory co-design approach, two design groups were convened and conducted separately via videoconferencing software: a hematologist group (HG, n=5) and a patient/caregiver group (PG, n=7). Three focus group sessions were conducted with HG, and two sessions with PG. Sessions lasted between 60 and 90 minutes. Short activities and question prompt lists were utilized to engage participants in the design sessions. Focus group transcripts were analyzed by two coders using rapid qualitative analysis, allowing the generation of actionable data for rapid tool development and iteration. The research team included researchers with extensive experience in communication tool development, clinical hematology, and user-centered methodologies. Results: The five enrolled hematologists had an average of 15.1 years of experience and had performed an average of 3 allo-SCTs in the past month. Four out of five hematologists were males. Six patients and one caregiver participated in PG sessions. Patients’ diagnoses spanned myelofibrosis, acute myeloid leukemia, and myelodysplastic syndrome. Two out of the six patients elected against undergoing allo_SCT. Participants’ educational level varied; 2/6 patients had a graduate or professional degree, 3/6 patients had some college, while one patient and the caregiver had a bachelor's degree. During the first session, both groups identified major challenges in allo-SCT consultations. Hematologists reported issues in distilling dense allo-SCT information, communicating uncertainty about prognosis and transplantation risks, and tailoring discussions to patients’ varying literacy, tolerance for uncertainty, and relationship status with providers. Patients and caregivers described allo-SCT consultations as overwhelming and voiced concerns about loss of autonomy by not being given other choices. They also reported needing in-depth information about their diagnosis and prognosis. These insights were used by researchers to develop three prototypes that were evaluated by HG in the second session for clarity, perceived usefulness, appropriateness, and acceptability. The session also explored areas for improvement. The prototype that achieved 80% consensus was later refined by the research team and presented to both groups in the final session. The tool received strong positive feedback from both groups, who provided minor suggestions to enhance its clarity and visual presentation. A final round of iteration by the research team led to the development of AlloTalk, a paper-based communication tool designed for consultations involving the discussion of allo-SCT regardless of the primary diagnosis. Conclusion: Using a participatory co-design approach, we developed a user-informed, theory-driven communication tool to guide allo-SCT consultations. To facilitate the dissemination and implementation of the tool in hematology clinics, future research will focus on creating a skills-based training program to help providers achieve competency in navigating the tool and integrating it into their consultations. Additionally, feasibility testing will be conducted to assess real-world usability and explore patients’ and providers’ experiences with AlloTalk.
DISCLOSURES
Bonyan Qudah, PhD: No relevant conflicts of interest to declare.